A patient with obesity, prediabetes, and cardiovascular disease would benefit significantly from semaglutide per the SELECT trial (Lincoff et al., New England Journal of Medicine 2023), which showed 20% reduction in major adverse cardiovascular events in non-diabetic patients treated with semaglutide
But because these medications significantly influence blood sugar regulation and digestive function, combining them with certain supplements can create unexpected risks
If you experience new or worsening foot symptoms while taking Ozempic or another GLP-1 drug, such as tingling, numbness, swelling, or slow-healing sores, its important to consult a podiatrist right away
It seems that fiber will take the spotlight in 2026, propelled by growing recognition of gut health's importance and social media trends like "fiber-maxxing"
More convenient pills could boost supply for the treatments as manufacturing and storage are easier